Day One Biopharmaceuticals, Inc. filed an amendment to their Restated Certificate of Incorporation to permit the exculpation of officers, which was approved by stockholders. They also held their 2023 Annual Meeting of Stockholders and adopted proposals for the election of directors and ratification of their independent registered public accounting firm.